$Cardiff Oncology (CRDF.US)$ Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer Tuesday, 15th April at 4:05 pm - Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ: CRDF), a c...
$Cardiff Oncology (CRDF.US)$👀 now this is what I'm talking about!! from looking at the all time chart . positive looking algorithm.✔️ insiders.✔️ big timer shareholders! ✔️nice voltility✔️ great price for long hold ✔️ who's going to the top with me?? I'm in!!!
4
Report
No comment yet
Sign in to post a comment
Market Insights
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Cardiff Oncology Stock Forum
Cardiff Oncology Announces a Second Patent for the Treatment of Mcrc for Bev-Naïve Patients
Major Progress: First-line Colorectal Cancer Treatment Trial Hits Key Milestone
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
Tuesday, 15th April at 4:05 pm
- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 -
- Additional clinical data from CRDF-004 trial expected in 1H 2025 -
SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ: CRDF), a c...
$SoFi Technologies (SOFI.US)$ $Palantir (PLTR.US)$ $Rockwell Automation (ROK.US)$
No comment yet